BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 5503601)

  • 21. Chromosomal characterization and isoenzyme pattern of non-malignant and malignant human urothelial cell lines.
    Debiec-Rychter M; Christensen B; Kieler J; Wang CY
    Anticancer Res; 1986; 6(5):1237-44. PubMed ID: 3800330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of a cell line from human transitional cell cancer of the urinary tract.
    Elliott AY; Cleveland P; Cervenka J; Castro AE; Stein N; Hakala TR; Fraley EE
    J Natl Cancer Inst; 1974 Nov; 53(5):1341-9. PubMed ID: 4431054
    [No Abstract]   [Full Text] [Related]  

  • 23. [Low-grade and low-stage transitional carcinoma of the bladder. Review].
    Escudero Barrilero A; Gutiérrez Sanz Gadea C; Hernández Fernández C; Romero Maroto J; Tallada Buñuel M; Perales Cabanas L
    Actas Urol Esp; 1985; 9(3):203-8. PubMed ID: 3898736
    [No Abstract]   [Full Text] [Related]  

  • 24. [Scanning electron microscopic observations of the normal transitional cell epithelium and transitional cell carcinoma of the urinary bladder].
    Kinoshita H
    Nihon Hinyokika Gakkai Zasshi; 1972 Aug; 63(8):649-57. PubMed ID: 4673894
    [No Abstract]   [Full Text] [Related]  

  • 25. Morphological, biological, and biochemical characteristics of human bladder transitional cell carcinomas grown in tissue culture and in nude mice.
    Kyriazis AA; Kyriazis AP; McCombs WB; Peterson WD
    Cancer Res; 1984 Sep; 44(9):3997-4005. PubMed ID: 6744315
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is chromosome 9 loss a marker of disease recurrence in transitional cell carcinoma of the urinary bladder?
    Bartlett JM; Watters AD; Ballantyne SA; Going JJ; Grigor KM; Cooke TG
    Br J Cancer; 1998 Jun; 77(12):2193-8. PubMed ID: 9649132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytogenetic analysis of 62 transitional cell bladder carcinomas.
    Granberg-Ohman I; Tribukait B; Wijkström H
    Cancer Genet Cytogenet; 1984 Jan; 11(1):69-85. PubMed ID: 6690024
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 5q deletion. The sole chromosome change in a carcinoma of the bladder.
    Atkin NB; Fox MF
    Cancer Genet Cytogenet; 1990 May; 46(1):129-31. PubMed ID: 2331676
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human bladder cancer grown as xenografts and in tissue culture as models of the biology and treatment of invasive bladder cancer.
    Russell PJ; Brown J; Russell P; Wass J; Carrington N; Raghavan D
    Eur Urol; 1988; 14 Suppl 1():15-6. PubMed ID: 3181233
    [No Abstract]   [Full Text] [Related]  

  • 30. Tissue culture of urinary bladder tumor induced in a rat by N-butyl-N-(-4-hydroxybutyl)nitrosamine: establishment of cell line, Nara Bladder Tumor II.
    Toyoshima K; Ito N; Hiasa Y; Kamamoto Y; Makiura S
    J Natl Cancer Inst; 1971 Nov; 47(5):979-85. PubMed ID: 4941696
    [No Abstract]   [Full Text] [Related]  

  • 31. Cellular heterogeneity in a tissue culture cell line derived from a human bladder carcinoma.
    Hastings RJ; Franks LM
    Br J Cancer; 1983 Feb; 47(2):233-44. PubMed ID: 6572066
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Establishment and characterization of a new cell line from human bladder cancer (JMSU1).
    Morita T; Shinohara N; Honma M; Tokue A
    Urol Res; 1995; 23(3):143-9. PubMed ID: 7483139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Establishment and characterization of a new human urinary bladder carcinoma cell line (PS-1).
    Sanford EJ; Geder L; Dagen JE; Laychock AM; Ladda R; Rohner TJ
    Invest Urol; 1978 Nov; 16(3):246-52. PubMed ID: 81814
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loss of cyclin-dependent kinase inhibitor genes and chromosome 9 karyotypic abnormalities in human bladder cancer cell lines.
    Southgate J; Proffitt J; Roberts P; Smith B; Selby P
    Br J Cancer; 1995 Nov; 72(5):1214-8. PubMed ID: 7577470
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chromosome pattern, growth in agar and tumorigenicity in nude mice of four human bladder carcinoma cell lines.
    Hastings RJ; Franks LM
    Int J Cancer; 1981 Jan; 27(1):15-21. PubMed ID: 7251229
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor behavior in transitional cell carcinoma of the bladder in relation to chromosomal markers and histopathology.
    Babu VR; Lutz MD; Miles BJ; Farah RN; Weiss L; Van Dyke DL
    Cancer Res; 1987 Dec; 47(24 Pt 1):6800-5. PubMed ID: 3479251
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Invasiveness of transformed bladder epithelial cells.
    Kieler JF
    Cancer Metastasis Rev; 1984; 3(3):265-96. PubMed ID: 6388825
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proliferation and ultrastructure of papillary transitional cell carcinoma of the human bladder.
    Fulker MJ; Cooper EH; Tanaka T
    Cancer; 1971 Jan; 27(1):71-82. PubMed ID: 4099701
    [No Abstract]   [Full Text] [Related]  

  • 39. Chromosomal high-polysomies predict tumour progression in T1 transitional cell carcinoma of the bladder.
    Ribal MJ; Alcaraz A; Mengual L; Carrio A; Lopez-Guillermo A; Mallofré C; Palou J; Gelabert A; Villavicencio H
    Eur Urol; 2004 May; 45(5):593-9. PubMed ID: 15082201
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Growth arrest and suppression of tumorigenicity of bladder-carcinoma cell lines induced by the P16/CDKN2 (p16INK4A, MTS1) gene and other loci on human chromosome 9.
    Wu Q; Possati L; Montesi M; Gualandi F; Rimessi P; Morelli C; Trabanelli C; Barbanti-Brodano G
    Int J Cancer; 1996 Mar; 65(6):840-6. PubMed ID: 8631601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.